Vibliome Therapeutics and AssayQuant Technologies, Inc. Establish Collaborative Relationship
- Tuesday, August 2, 2022, 7:00
- Finance
- Add a comment
BOZEMAN, Mont. and MARLBOROUGH, Mass., Aug. 2, 2022 /PRNewswire/ — Vibliome Therapeutics, LLC, and AssayQuant Technologies, Inc., announced today that they have entered into an agreement whereby AssayQuant will provide Vibliome access to their proprietary PhosphoSens® Technology for…
About the Author
adminasapcorp has written 39120 stories on this site.